Home / TGF-beta RII / Human TGF-beta  RII Antibody

Human TGF-beta  RII Antibody

Catalog #: AF-241-NA
38 Citations Datasheet / COA / SDS
Catalog # Availability Size / Price Qty
AF-241-NA
AF-241-SP
Best Seller
Detection of Human TGF‑ beta RII by Western Blot.
4 Images
Product Details
Citations (38)
FAQs
Supplemental Products
Reviews
Summary Data Examples Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Human TGF-beta  RII Antibody Summary

Species Reactivity
Human
Specificity
Detects human TGF-beta RII in direct ELISAs and Western blots.
Source
Polyclonal Goat IgG
Purification
Antigen Affinity-purified
Immunogen
Mouse myeloma cell line NS0-derived recombinant human TGF‑ beta  RII
Ile24-Asp159
Accession # P37173.2
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Label
Unconjugated

Applications

Recommended Concentration
Sample
Western Blot
2 µg/mL
See below
Flow Cytometry
1 µg/106 cells
See below
Immunohistochemistry
5-15 µg/mL
See below
CyTOF-ready
Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.
 

Human TGF-beta RII Sandwich Immunoassay

Recommended Concentration
Reagent
ELISA Capture (Matched Antibody Pair)
0.2-0.8 µg/mL 

Use in combination with:

Detection Reagent: Human TGF‑ beta  RII Biotinylated Antibody (Catalog # BAF241)

Standard: Recombinant Human TGF-beta RII Protein (Catalog # 241-R2)

Neutralization
Measured by its ability to neutralize TGF‑ beta 1 inhibition of IL‑4-dependent proliferation in the TF‑1 human erythroleukemic cell line. Tsang, M. et al. (1995) Cytokine 7:389. The Neutralization Dose (ND50) is typically 5‑20 µg/mL in the presence of 0.04 ng/mL Recombinant Human TGF‑ beta 1 and 5 ng/mL Recombinant Human IL‑4.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Western Blot Detection of Human TGF-beta RII antibody by Western Blot. View Larger

Detection of Human TGF‑ beta RII by Western Blot. Western blot shows lysates of HepG2 human hepatocellular carcinoma cell line, Hep3B human hepatocellular carcinoma cell line, U-118-MG human glioblastoma/astrocytoma cell line, HT1080 human fibrosarcoma cell line, and DU145 human prostate carcinoma cell line. PVDF membrane was probed with 2 µg/mL of Goat Anti-Human TGF-beta RII Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-241-NA) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (HAF017). A specific band was detected for TGF-beta RII at approximately 75 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

Flow Cytometry Detection of TGF-beta RII antibody in Human Lymphocytes antibody by Flow Cytometry. View Larger

Detection of TGF-beta RII in Human Lymphocytes by Flow Cytometry. Human blood-derived lymphocytes were labeled with Goat Anti-Human TGF-beta RII Antigen Affinity-purified Poly-clonal Antibody (Catalog # AF-241-NA, filled histogram) or control antibody (AB-108-C, open histogram), followed by Allophycocyanin-conjugated Anti-Goat IgG Secondary Antibody (F0108).

Immunohistochemistry TGF-beta RII antibody in Human Pituitary by Immunohistochemistry (IHC-P). View Larger

TGF-beta RII in Human Pituitary. TGF-beta RII was detected in immersion fixed paraffin-embedded sections of human pituitary using Goat Anti-Human TGF-beta RII Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-241-NA) at 15 µg/mL overnight at 4 °C. Tissue was stained using the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; (CTS008) and counterstained with hematoxylin (blue). Lower panel shows a lack of labeling if primary antibodies are omitted and tissue is stained only with secondary antibody followed by incubation with detection reagents. View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.

Neutralization TGF‑ beta 1 Inhibition of IL‑4-dependent Cell Proliferation and Neutralization by Human TGF‑ beta RII Antibody. View Larger

TGF‑ beta 1 Inhibition of IL‑4-dependent Cell Proliferation and Neutralization by Human TGF‑ beta RII Antibody. Recombinant Human TGF-beta 1 (Catalog # 240-B) inhibits Recombinant Human IL-4 (Catalog # 204-IL) induced proliferation in the TF-1 human erythroleukemic cell line in a dose-dependent manner (orange line). Inhibition of Recombinant Human IL-4 (5 ng/mL) activity elicited by Recombinant Human TGF-beta 1 (0.04 ng/mL) is neutral-ized (green line) by increasing concentrations of Goat Anti- Human TGF-beta RII Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-241-NA). The ND50 is typically 10-20 µg/mL.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Loading...
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: TGF-beta RII

TGF-beta RII is a membrane bound serine/threonine kinase. Upon ligand binding, TGF-beta RII interacts with TGF-beta RI to form the heteromeric signaling complex thattransduces TGF beta signals. A splice variant of the type II receptor, TGF-beta RIIb, containing a 25 amino acid residue insertion near the Nterminus of the mature protein has also been described.

Long Name
Transforming Growth Factor beta Receptor II
Entrez Gene IDs
7048 (Human); 21813 (Mouse)
Alternate Names
AAT3; EC 2.7.11; EC 2.7.11.30; FAA3; HNPCC6; LDS1B; LDS2B; MFS2; RIIC; TAAD2; tbetaR-II; TGF-beta receptor type II; TGF-beta receptor type IIB; TGF-beta receptor type-2; TGF-beta RII; TGF-beta type II receptor; TGFbetaRII; TGFbeta-RII; TGFBR2; TGF-bRII; TGFR-2; transforming growth factor beta receptor type IIC; transforming growth factor, beta receptor II (70/80kDa) isoform 1; transforming growth factor, beta receptor II (70/80kDa) isoform 2; transforming growth factor, beta receptor II (70/80kDa); transforming growth factor, beta receptor II (70-80kD); Transforming growth factor-beta receptor type II

Product Datasheets

You must select a language.

x
Product Datasheet
COA
SDS

Citations for Human TGF-beta  RII Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

38 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF beta.
    Authors: Massam-Wu T, Chiu M, Choudhury R
    J. Cell. Sci., 2010-08-10;123(0):3006-18.
  2. Induction of Reactive Bone Stromal Fibroblasts in 3D Models of Prostate Cancer Bone Metastases
    Authors: Windus, LCE;Matigian, N;Avery, VM;
    Biology
    Species: Human
    Sample Types: Cell Lysates, Whole Cells
    Applications: Western Blot, ICC
  3. Neuropilin-1 interacts with VE-cadherin and TGFBR2 to stabilize adherens junctions and prevent activation of endothelium under flow
    Authors: Emy Bosseboeuf, Anissa Chikh, Ahmed Bey Chaker, Tom P. Mitchell, Dhilakshani Vignaraja, Ridhi Rajendrakumar et al.
    Science Signaling
  4. TGF-beta is elevated in hyperuricemic individuals and mediates urate-induced hyperinflammatory phenotype in human mononuclear cells
    Authors: V Klück, G Cab?u, L Mies, F Bukkems, L van Emst, R Bakker, A van Caam, HINT conso, TO Cri?an, LAB Joosten
    Arthritis Research & Therapy, 2023-02-27;25(1):30.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  5. GARP Regulates the Immune Capacity of a Human Autologous Platelet Concentrate
    Authors: ER Trzeciak, N Zimmer, PW Kämmerer, D Thiem, B Al-Nawas, A Tuettenber, S Blatt
    Biomedicines, 2022-12-05;10(12):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Functional Assay
  6. Fungal sensing by dectin-1 directs the non-pathogenic polarization of TH17 cells through balanced type I IFN responses in human DCs
    Authors: SI Gringhuis, TM Kaptein, EBM Remmerswaa, A Drewniak, BA Wevers, B Theelen, GRAM D'Haens, T Boekhout, TBH Geijtenbee
    Nature Immunology, 2022-12-01;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  7. Recruitment of LEF1 by Pontin chromatin modifier amplifies TGFBR2 transcription and activates TGFbeta/SMAD signalling during gliomagenesis
    Authors: X Zhou, X Li, R Wang, D Hua, C Sun, L Yu, C Shi, W Luo, Z Jiang, W An, Q Wang, S Yu
    Cell Death & Disease, 2022-09-24;13(9):818.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  8. Low-Dose-Rate Radiation-Induced Secretion of TGF-beta3 Together with an Activator in Small Extracellular Vesicles Modifies Low-Dose Hyper-Radiosensitivity through ALK1 Binding
    Authors: I Hanson, KE Pitman, U Altanerova, ? Altaner, E Malinen, NFJ Edin
    International Journal of Molecular Sciences, 2022-07-24;23(15):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  9. Prevention of bleomycin-induced pulmonary fibrosis by a RANKL peptide in mice
    Authors: N Ju, H Hayashi, M Shimamura, S Baba, S Yoshida, R Morishita, H Rakugi, H Nakagami
    Scientific Reports, 2022-07-21;12(1):12474.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  10. Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanism
    Authors: Mengwen Zhang, Xingyi Pan, Kenji Fujiwara, Noelle Jurcak, Stephen Muth, Jiaojiao Zhou et al.
    Signal Transduction and Targeted Therapy
  11. Platelet-Derived GARP Induces Peripheral Regulatory T Cells-Potential Impact on T Cell Suppression in Patients with Melanoma-Associated Thrombocytosis
    Authors: N Zimmer, FK Krebs, S Zimmer, H Mitzel-Rin, EJ Kumm, K Jurk, S Grabbe, C Loquai, A Tuettenber
    Cancers, 2020-12-05;12(12):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Cell Culture
  12. PAI-1-Dependent Inactivation of SMAD4-Modulated Junction and Adhesion Complex in Obese Endometrial Cancer
    Authors: LL Lin, ER Kost, CL Lin, P Valente, CM Wang, MG Kolonin, AC Daquinag, X Tan, N Lucio, CN Hung, CP Wang, NB Kirma, TH Huang
    Cell Rep, 2020-10-13;33(2):108253.
    Species: Human
    Sample Types: Whole Cells
    Applications: CyTof
  13. Inhibition of TGF-beta 1 Signaling by IL-15: A Novel Role for IL-15 in the Control of Renal Epithelial-Mesenchymal Transition: IL-15 Counteracts TGF-beta 1-Induced EMT in Renal Fibrosis
    Authors: Aurore Devocelle, Lola Lecru, Hélène François, Christophe Desterke, Cindy Gallerne, Pierre Eid et al.
    International Journal of Cell Biology
  14. Inhibition of IL-10 and TGF-? receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells
    Authors: C Thepmalee, A Panya, M Junking, T Chieochans, PT Yenchitsom
    Hum Vaccin Immunother, 2018-02-21;0(0):0.
    Species: Human
    Sample Types: Cell Lysates, Whole Cells
    Applications: Neutralization, Western Blot
  15. TGF-? contamination of purified recombinant GDF15
    Authors: OE Olsen, A Skjærvik, BF Størdal, A Sundan, T Holien
    PLoS ONE, 2017-11-21;12(11):e0187349.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  16. 24R,25-Dihydroxyvitamin D3 Protects against Articular Cartilage Damage following Anterior Cruciate Ligament Transection in Male Rats
    PLoS ONE, 2016-08-30;11(8):e0161782.
    Species: Rat
    Sample Types: Whole Cells
    Applications: Blocking
  17. Clathrin light chains' role in selective endocytosis influences antibody isotype switching
    Proc Natl Acad Sci USA, 2016-08-18;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  18. Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
    Authors: Kenny H, Chiang C, White E, Schryver E, Habis M, Romero I, Ladanyi A, Penicka C, George J, Matlin K, Montag A, Wroblewski K, Yamada S, Mazar A, Bowtell D, Lengyel E
    J Clin Invest, 2014-09-09;124(10):4614-28.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  19. T-cell TGF-beta signaling abrogation restricts medulloblastoma progression.
    Authors: Gate D, Danielpour M, Rodriguez J, Kim G, Levy R, Bannykh S, Breunig J, Kaech S, Flavell R, Town T
    Proc Natl Acad Sci U S A, 2014-07-31;111(33):E3458-66.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC
  20. Integrin-mediated type II TGF-beta receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.
    Authors: Chen X, Wang H, Liao H, Hu W, Gewin L, Mernaugh G, Zhang S, Zhang Z, Vega-Montoto L, Vanacore R, Fassler R, Zent R, Pozzi A
    J Clin Invest, 2014-07-01;124(8):3295-310.
    Species: Mouse
    Sample Types: Cell Lysates
    Applications: Neutralization
  21. CD4+CD25+ T regulatory cells activated during feline immunodeficiency virus infection convert T helper cells into functional suppressors through a membrane-bound TGFbeta / GARP-mediated mechanism.
    Authors: Miller M, Petty C, Tompkins M, Fogle J
    Virol J, 2014-01-18;11(0):7.
    Species: Feline
    Sample Types: Whole Cells
    Applications: Neutralization
  22. Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of alphavbeta6 integrin in DCIS identifies high-risk patients and predicts recurrence.
    Authors: Allen M, Thomas G, Clark S, Dawoud M, Vallath S, Payne S, Gomm J, Dreger S, Dickinson S, Edwards D, Pennington C, Sestak I, Cuzick J, Marshall J, Hart I, Jones J
    Clin Cancer Res, 2013-10-22;20(2):344-57.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neutralization
  23. Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin alpha V beta 3 and RhoA/ROCK-mediated mechanisms☆
    Authors: Kirsten Riches, Larissa Franklin, Azhar Maqbool, Michelle Peckham, Matthew Adams, Jacquelyn Bond et al.
    The International Journal of Biochemistry & Cell Biology
  24. Feline glycoprotein A repetitions predominant anchors transforming growth factor beta on the surface of activated CD4(+)CD25(+) regulatory T cells and mediates AIDS lentivirus-induced T cell immunodeficiency
    Authors: Michelle M. Miller, Jonathan E. Fogle, Peter Ross, Mary B. Tompkins
    AIDS Research and Human Retroviruses
  25. TGF-beta mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells.
    Authors: Shinojima N, Hossain A, Takezaki T, Fueyo J, Gumin J, Gao F, Nwajei F, Marini F, Andreeff M, Kuratsu J, Lang F
    Cancer Res, 2013-01-30;73(7):2333-44.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  26. Role of gastric epithelial cell-derived transforming growth factor beta in reduced CD4+ T cell proliferation and development of regulatory T cells during Helicobacter pylori infection
    Authors: Ellen J. Beswick, Iryna V. Pinchuk, Rachel B. Earley, David A. Schmitt, Victor E. Reyes
    Infection and Immunity
  27. Influence of thrombophlebitis on TGF-β1 and its signaling pathway in the vein wall
    Authors: Radoslaw Kowalewski, Andrzej Malkowski, Marek Gacko, Krzysztof Sobolewski
    Folia Histochemica et Cytobiologica
  28. Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis.
    Authors: Rai D, Kim SW, McKeller MR
    Proc. Natl. Acad. Sci. U.S.A., 2010-02-01;107(7):3111-6.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  29. Evaluation of transforming growth factor-beta signaling pathway in the wall of normal and varicose veins
    Authors: Radoslaw Kowalewski, Andrzej Malkowski, Krzysztof Sobolewski, Marek Gacko
    Pathobiology
  30. Activation of TGF-beta within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor
    Authors: Olav A. Gressner, Birgit Lahme, Monika Siluschek, Katharina Rehbein, Jens Herrmann, Ralf Weiskirchen et al.
    Journal of Cellular and Molecular Medicine
  31. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism.
    Authors: Van Aarsen LA, Leone DR, Ho S, Dolinski BM, McCoon PE, LePage DJ, Kelly R, Heaney G, Rayhorn P, Reid C, Simon KJ, Horan GS, Tao N, Gardner HA, Skelly MM, Gown AM, Thomas GJ, Weinreb PH, Fawell SE, Violette SM
    Cancer Res., 2008-01-15;68(2):561-70.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  32. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1.
    Authors: Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR, Wu L, Pankhurst G, Jiang L, Junankar S, Hunter M, Fairlie WD, Lee NJ, Enriquez RF, Baldock PA, Corey E, Apple FS, Murakami MM, Lin EJ, Wang C, During MJ, Sainsbury A, Herzog H, Breit SN
    Nat. Med., 2007-11-04;13(11):1333-40.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  33. Fibrillin-1 regulates the bioavailability of TGFbeta1
    Authors: Shazia S. Chaudhry, Stuart A. Cain, Amanda Morgan, Sarah L. Dallas, C. Adrian Shuttleworth, Cay M. Kielty
    The Journal of Cell Biology
  34. Very low O2 concentration (0.1%) favors G0 return of dividing CD34+ cells.
    Authors: Hermitte F, Brunet de la Grange P, Belloc F, Praloran V, Ivanovic Z
    Stem Cells, 2005-08-25;24(1):65-73.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  35. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function.
    Authors: Godfrey WR, Spoden DJ, Ge YG, Baker SR, Liu B, Levine BL, June CH, Blazar BR, Porter SB
    Blood, 2004-09-16;105(2):750-8.
    Species: Human
    Sample Types: Cell Culture Supernates
    Applications: Neutralization
  36. Transforming growth factor-beta1 regulation of growth zone chondrocytes is mediated by multiple interacting pathways.
    Authors: Rosado E, 2019, Schwartz Z, Sylvia VL, Dean DD, Boyan BD
    91, 2002-06-12;1590(1):1-15.
    Species: Rat
    Sample Types: Whole Cells
    Applications: Neutralization
  37. TGF-beta1 regulates TGF-beta1 and FGF-2 mRNA expression during fibroblast wound healing.
    Authors: Song QH, Klepeis VE, Trinkaus-Randall V
    MP, Mol. Pathol., 2002-06-01;55(3):164-76.
    Species: Rabbit
    Sample Types: Whole Tissue
    Applications: IHC
  38. CD4(+)CD25(+) T regulatory cells inhibit CD8(+) IFN-gamma production during acute and chronic FIV infection utilizing a membrane TGF-beta-dependent mechanism.
    Authors: Fogle JE, Mexas AM, Tompkins WA, Tompkins MB
    AIDS Res. Hum. Retroviruses, 2010-02-01;26(2):201-16.

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs
Loading...

Reviews for Human TGF-beta  RII Antibody

There are currently no reviews for this product. Be the first to review Human TGF-beta  RII Antibody and earn rewards!

Have you used Human TGF-beta  RII Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review